{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:02:33Z","timestamp":1778544153189,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"DOI":"10.7759\/cureus.61599","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T16:38:56Z","timestamp":1717432736000},"source":"Crossref","is-referenced-by-count":1,"title":["Exploring Splice-Site Mutations in LAMA2-Related Muscular Dystrophies: A Comprehensive Analysis of Genotypic and Phenotypic Patterns"],"prefix":"10.7759","author":[{"given":"Samira","family":"Nmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Ameli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Trhanint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Chaouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Bouguenouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Ouldim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1604154","article-title":"Congenital muscular dystrophies and myopathies: an overview and update","volume":"48","author":"Schorling DC","year":"2017","unstructured":"Schorling DC, Kirschner J, B\u00f6nnemann CG. Congenital muscular dystrophies and myopathies: an overview and update. Neuropediatrics. 2017, 48:247-61. 10.1055\/s-0037-1604154","journal-title":"Neuropediatrics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.12.011","article-title":"Diagnostic approach to the congenital muscular dystrophies","volume":"24","author":"B\u00f6nnemann CG","year":"2014","unstructured":"B\u00f6nnemann CG, Wang CH, Quijano-Roy S, et al.. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014, 24:289-311. 10.1016\/j.nmd.2013.12.011","journal-title":"Neuromuscul Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2004.06.009","article-title":"The congenital muscular dystrophies in 2004: a century of exciting progress","volume":"14","author":"Muntoni F","year":"2004","unstructured":"Muntoni F, Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul Disord. 2004, 14:635-49. 10.1016\/j.nmd.2004.06.009","journal-title":"Neuromuscul Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-1-9","article-title":"Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies","volume":"1","author":"Gawlik KI","year":"2011","unstructured":"Gawlik KI, Durbeej M. Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet Muscle. 2011, 1:9. 10.1186\/2044-5040-1-9","journal-title":"Skelet Muscle"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00123","article-title":"LAMA2-related dystrophies: clinical phenotypes, disease biomarkers, and clinical trial readiness","volume":"13","author":"Sarkozy A","year":"2020","unstructured":"Sarkozy A, Foley AR, Zambon AA, B\u00f6nnemann CG, Muntoni F. LAMA2-related dystrophies: clinical phenotypes, disease biomarkers, and clinical trial readiness. Front Mol Neurosci. 2020, 13:123. 10.3389\/fnmol.2020.00123","journal-title":"Front Mol Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2010.02.001","article-title":"Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations","volume":"20","author":"Geranmayeh F","year":"2010","unstructured":"Geranmayeh F, Clement E, Feng LH, et al.. Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord. 2010, 20:241-50. 10.1016\/j.nmd.2010.02.001","journal-title":"Neuromuscul Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2013.11.002","article-title":"High creatine kinase levels and white matter changes: clinical and genetic spectrum of congenital muscular dystrophies with laminin alpha-2 deficiency","volume":"28","author":"Beyt\u00eda Mde L","year":"2014","unstructured":"Beyt\u00eda Mde L, Dekomien G, Hoffjan S, Haug V, Anastasopoulos C, Kirschner J. High creatine kinase levels and white matter changes: clinical and genetic spectrum of congenital muscular dystrophies with laminin alpha-2 deficiency. Mol Cell Probes. 2014, 28:118-22. 10.1016\/j.mcp.2013.11.002","journal-title":"Mol Cell Probes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.10.649","article-title":"The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review","volume":"38","author":"Jones KJ","year":"2001","unstructured":"Jones KJ, Morgan G, Johnston H, Tobias V, Ouvrier RA, Wilkinson I, North KN. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J Med Genet. 2001, 38:649-57. 10.1136\/jmg.38.10.649","journal-title":"J Med Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23599","article-title":"LAMA2 gene mutation update: toward a more comprehensive picture of the laminin-\u03b12 variome and its related phenotypes","volume":"39","author":"Oliveira J","year":"2018","unstructured":"Oliveira J, Gruber A, Cardoso M, et al.. LAMA2 gene mutation update: toward a more comprehensive picture of the laminin-\u03b12 variome and its related phenotypes. Hum Mutat. 2018, 39:1314-37. 10.1002\/humu.23599","journal-title":"Hum Mutat"},{"key":"ref10","unstructured":"ClinVar. lama2[gene]. (2013). Accessed: January 10, 2024: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/?term=lama2%5Bgene%5D&amp;redir=gene.."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/gte.2006.0517","article-title":"Severe MDC1A congenital muscular dystrophy due to a splicing mutation in the LAMA2 gene resulting in exon skipping and significant decrease of mRNA level","volume":"11","author":"Siala O","year":"2007","unstructured":"Siala O, Louhichi N, Triki C, et al.. Severe MDC1A congenital muscular dystrophy due to a splicing mutation in the LAMA2 gene resulting in exon skipping and significant decrease of mRNA level. Genet Test. 2007, 11:199-207. 10.1089\/gte.2006.0517","journal-title":"Genet Test"},{"key":"ref12","unstructured":"LOVD database. (2022). Accessed. January 23, 2024: https:\/\/databases.lovd.nl\/shared\/variants\/LAMA2\/unique."},{"key":"ref13","unstructured":"dbSNP. rs749522728. (2022). Accessed: January 23, 2024: https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs749522728.."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2350\/06-07-0127.1","article-title":"The congenital muscular dystrophies: recent advances and molecular insights","volume":"9","author":"Mendell JR","year":"2006","unstructured":"Mendell JR, Bou\u00e9 DR, Martin PT. The congenital muscular dystrophies: recent advances and molecular insights. Pediatr Dev Pathol. 2006, 9:427-43. 10.2350\/06-07-0127.1","journal-title":"Pediatr Dev Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-004-1398-y","article-title":"Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI","volume":"35","author":"Leite CC","year":"2005","unstructured":"Leite CC, Lucato LT, Martin MG, et al.. Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI. Pediatr Radiol. 2005, 35:572-9. 10.1007\/s00247-004-1398-y","journal-title":"Pediatr Radiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3678-13.2014","article-title":"The extracellular matrix protein laminin \u03b12 regulates the maturation and function of the blood-brain barrier","volume":"34","author":"Menezes MJ","year":"2014","unstructured":"Menezes MJ, McClenahan FK, Leiton CV, Aranmolate A, Shan X, Colognato H. The extracellular matrix protein laminin \u03b12 regulates the maturation and function of the blood-brain barrier. J Neurosci. 2014, 34:15260-80. 10.1523\/JNEUROSCI.3678-13.2014","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01950-x","article-title":"Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort","volume":"16","author":"Tan D","year":"2021","unstructured":"Tan D, Ge L, Fan Y, et al.. Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort. Orphanet J Rare Dis. 2021, 16:319. 10.1186\/s13023-021-01950-x","journal-title":"Orphanet J Rare Dis"},{"key":"ref18","article-title":"Novel mutations in LAMA2 gene responsible for a severe phenotype of congenital muscular dystrophy in two Tunisian families","volume":"83","author":"Louhichi N","year":"2006","unstructured":"Louhichi N, Richard P, Triki CH, Meziou M, Ayadi H, Guicheney P, Fakhfakh F. Novel mutations in LAMA2 gene responsible for a severe phenotype of congenital muscular dystrophy in two Tunisian families. Arch Inst Pasteur Tunis. 2006, 83:19-23.","journal-title":"Arch Inst Pasteur Tunis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(98)01208-0","article-title":"A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance","volume":"23","author":"Nagy E","year":"1998","unstructured":"Nagy E, Maquat LE. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci. 1998, 23:198-9. 10.1016\/S0968-0004(98)01208-0","journal-title":"Trends Biochem Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J","article-title":"Protein misfolding and degradation in genetic diseases","volume":"14","author":"Bross P","year":"1999","unstructured":"Bross P, Corydon TJ, Andresen BS, J\u00f8rgensen MM, Bolund L, Gregersen N. Protein misfolding and degradation in genetic diseases. Hum Mutat. 1999, 14:3-186. 10.1002\/(SICI)1098-1004(1999)14:3&lt;186::AID-HUMU2&gt;3.0.CO;2-J","journal-title":"Hum Mutat"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.986372","article-title":"COL1A1 novel splice variant in osteogenesis imperfecta and splicing variants review: a case report","volume":"9","author":"Dirani M","year":"2022","unstructured":"Dirani M, Cuenca VD, Romero VI. COL1A1 novel splice variant in osteogenesis imperfecta and splicing variants review: a case report. Front Surg. 2022, 9:986372. 10.3389\/fsurg.2022.986372","journal-title":"Front Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2017.03.008","article-title":"MYO15A splicing mutations in hearing loss: a review literature and report of a novel mutation","volume":"96","author":"Motavaf M","year":"2017","unstructured":"Motavaf M, Soveizi M, Maleki M, Mahdieh N. MYO15A splicing mutations in hearing loss: a review literature and report of a novel mutation. Int J Pediatr Otorhinolaryngol. 2017, 96:35-8. 10.1016\/j.ijporl.2017.03.008","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.5.747","article-title":"Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain","volume":"6","author":"Allamand V","year":"1997","unstructured":"Allamand V, Sunada Y, Salih MA, et al.. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. Hum Mol Genet. 1997, 6:747-52. 10.1093\/hmg\/6.5.747","journal-title":"Hum Mol Genet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-534","article-title":"Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T &gt; C mutation of LAMA2","volume":"4","author":"Di Blasi C","year":"2011","unstructured":"Di Blasi C, Bellafiore E, Salih MA, et al.. Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T &amp;gt; C mutation of LAMA2. BMC Res Notes. 2011, 4:534. 10.1186\/1756-0500-4-534","journal-title":"BMC Res Notes"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2008.01068.x","article-title":"LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients","volume":"74","author":"Oliveira J","year":"2008","unstructured":"Oliveira J, Santos R, Soares-Silva I, et al.. LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients. Clin Genet. 2008, 74:502-12. 10.1111\/j.1399-0004.2008.01068.x","journal-title":"Clin Genet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3233\/JND-221638","article-title":"Brain MRI abnormalities, epilepsy and intellectual disability in LAMA2 related dystrophy - a genotype\/phenotype correlation","volume":"10","author":"Camelo CG","year":"2023","unstructured":"Camelo CG, Artilheiro MC, Martins Moreno CA, et al.. Brain MRI abnormalities, epilepsy and intellectual disability in LAMA2 related dystrophy - a genotype\/phenotype correlation. J Neuromuscul Dis. 2023, 10:483-92. 10.3233\/JND-221638","journal-title":"J Neuromuscul Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2014.01.004","article-title":"Atypical phenotype in two patients with LAMA2 mutations","volume":"24","author":"Marques J","year":"2014","unstructured":"Marques J, Duarte ST, Costa S, et al.. Atypical phenotype in two patients with LAMA2 mutations. Neuromuscul Disord. 2014, 24:419-24. 10.1016\/j.nmd.2014.01.004","journal-title":"Neuromuscul Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10157","article-title":"Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency","volume":"21","author":"Tezak Z","year":"2003","unstructured":"Tezak Z, Prandini P, Boscaro M, et al.. Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency. Hum Mutat. 2003, 21:103-11. 10.1002\/humu.10157","journal-title":"Hum Mutat"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.1.31","article-title":"Mutations in the laminin alpha2-chain gene in two children with early-onset muscular dystrophy","volume":"123 ( Pt 1)","author":"Naom I","year":"2000","unstructured":"Naom I, D'alessandro M, Sewry CA, et al.. Mutations in the laminin alpha2-chain gene in two children with early-onset muscular dystrophy. Brain. 2000, 123 ( Pt 1):31-41. 10.1093\/brain\/123.1.31","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-023-00416-y","article-title":"Early diagnosis of congenital muscular pathologies using next-generation sequencing: experiences from a tertiary center in Morocco","volume":"24","author":"El Kadiri Y","year":"2023","unstructured":"El Kadiri Y, Ratbi I, Ouhenach M, et al.. Early diagnosis of congenital muscular pathologies using next-generation sequencing: experiences from a tertiary center in Morocco. Egypt J Med Hum Genet. 2023, 24:36. 10.1186\/s43042-023-00416-y","journal-title":"Egypt J Med Hum Genet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12810","article-title":"Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population","volume":"91","author":"Fattahi Z","year":"2017","unstructured":"Fattahi Z, Kalhor Z, Fadaee M, et al.. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population. Clin Genet. 2017, 91:386-402. 10.1111\/cge.12810","journal-title":"Clin Genet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170517","article-title":"Comprehensive target capture\/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan","volume":"12","author":"Liang WC","year":"2017","unstructured":"Liang WC, Tian X, Yuo CY, et al.. Comprehensive target capture\/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan. PLoS One. 2017, 12:e0170517. 10.1371\/journal.pone.0170517","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.09.003","article-title":"LAMA2 mRNA processing alterations generate a complete deficiency of laminin-alpha2 protein and a severe congenital muscular dystrophy","volume":"18","author":"Siala O","year":"2008","unstructured":"Siala O, Louhichi N, Triki C, Morini\u00e8re M, Fakhfakh F, Baklouti F. LAMA2 mRNA processing alterations generate a complete deficiency of laminin-alpha2 protein and a severe congenital muscular dystrophy. Neuromuscul Disord. 2008, 18:137-45. 10.1016\/j.nmd.2007.09.003","journal-title":"Neuromuscul Disord"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2007.05.008","article-title":"Severe congenital muscular dystrophy in a LAMA2-mutated case","volume":"37","author":"Di Blasi C","year":"2007","unstructured":"Di Blasi C, van Alfen N, Colleoni F, ter Laak H, Mora M. Severe congenital muscular dystrophy in a LAMA2-mutated case. Pediatr Neurol. 2007, 37:212-4. 10.1016\/j.pediatrneurol.2007.05.008","journal-title":"Pediatr Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24588","article-title":"LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies","volume":"52","author":"L\u00f8kken N","year":"2015","unstructured":"L\u00f8kken N, Born AP, Duno M, Vissing J. LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies. Muscle Nerve. 2015, 52:547-53. 10.1002\/mus.24588","journal-title":"Muscle Nerve"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33098-3","article-title":"Deletion of exon 4 in LAMA2 is the most frequent mutation in Chinese patients with laminin \u03b12-related muscular dystrophy","volume":"8","author":"Ge L","year":"2018","unstructured":"Ge L, Liu A, Gao K, et al.. Deletion of exon 4 in LAMA2 is the most frequent mutation in Chinese patients with laminin \u03b12-related muscular dystrophy. Sci Rep. 2018, 8:14989. 10.1038\/s41598-018-33098-3","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.57.7.1319","article-title":"Congenital muscular dystrophy with primary partial laminin alpha2 chain deficiency: molecular study","volume":"57","author":"He Y","year":"2001","unstructured":"He Y, Jones KJ, Vignier N, et al.. Congenital muscular dystrophy with primary partial laminin alpha2 chain deficiency: molecular study. Neurology. 2001, 57:1319-22. 10.1212\/wnl.57.7.1319","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.29252\/.22.6.408","article-title":"Novel LAMA2 gene mutations associated with merosin-deficient congenital muscular dystrophy","volume":"22","author":"Hashemi-Gorji F","year":"2018","unstructured":"Hashemi-Gorji F, Yassaee VR, Dashti P, Miryounesi M. Novel LAMA2 gene mutations associated with merosin-deficient congenital muscular dystrophy. Iran Biomed J. 2018, 22:408-14. 10.29252\/.22.6.408","journal-title":"Iran Biomed J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16493","article-title":"Epilepsy in LAMA2-related muscular dystrophy: an electro-clinico-radiological characterization","volume":"61","author":"Natera-de Benito D","year":"2020","unstructured":"Natera-de Benito D, Muchart J, Itzep D, et al.. Epilepsy in LAMA2-related muscular dystrophy: an electro-clinico-radiological characterization. Epilepsia. 2020, 61:971-83. 10.1111\/epi.16493","journal-title":"Epilepsia"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24687","article-title":"Diagnosis and etiology of congenital muscular dystrophy: we are halfway there","volume":"80","author":"O'Grady GL","year":"2016","unstructured":"O'Grady GL, Lek M, Lamande SR, et al.. Diagnosis and etiology of congenital muscular dystrophy: we are halfway there. Ann Neurol. 2016, 80:101-11. 10.1002\/ana.24687","journal-title":"Ann Neurol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2016.116","article-title":"The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States","volume":"62","author":"Reddy HM","year":"2017","unstructured":"Reddy HM, Cho KA, Lek M, et al.. The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States. J Hum Genet. 2017, 62:243-52. 10.1038\/jhg.2016.116","journal-title":"J Hum Genet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/s41439-020-0103-5","article-title":"Novel LAMA2 variants identified in a patient with white matter abnormalities","volume":"7","author":"Yamamoto-Shimojima K","year":"2020","unstructured":"Yamamoto-Shimojima K, Ono H, Imaizumi T, Yamamoto T. Novel LAMA2 variants identified in a patient with white matter abnormalities. Hum Genome Var. 2020, 7:16. 10.1038\/s41439-020-0103-5","journal-title":"Hum Genome Var"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7165","article-title":"RNA analysis of intronic variants in the LAMA2 gene detected by whole genome sequencing confirms a rare dual diagnosis of incontinentia pigmenti with limb-girdle muscular dystrophy","volume":"11","author":"Washington C","year":"2023","unstructured":"Washington C, Stolerman ES, Cooley-Coleman JA, Jones JR, Chen-Deutsch X. RNA analysis of intronic variants in the LAMA2 gene detected by whole genome sequencing confirms a rare dual diagnosis of incontinentia pigmenti with limb-girdle muscular dystrophy. Clin Case Rep. 2023, 11:e7165. 10.1002\/ccr3.7165","journal-title":"Clin Case Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175343","article-title":"Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing","volume":"12","author":"Yu M","year":"2017","unstructured":"Yu M, Zheng Y, Jin S, et al.. Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing. PLoS One. 2017, 12:e0175343. 10.1371\/journal.pone.0175343","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22196","article-title":"Clinical and pathological heterogeneity in late-onset partial merosin deficiency","volume":"44","author":"Rajakulendran S","year":"2011","unstructured":"Rajakulendran S, Parton M, Holton JL, Hanna MG. Clinical and pathological heterogeneity in late-onset partial merosin deficiency. Muscle Nerve. 2011, 44:590-3. 10.1002\/mus.22196","journal-title":"Muscle Nerve"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/genes9110524","article-title":"Copy number variants account for a tiny fraction of undiagnosed myopathic patients","volume":"9","author":"Giugliano T","year":"2018","unstructured":"Giugliano T, Savarese M, Garofalo A, et al.. Copy number variants account for a tiny fraction of undiagnosed myopathic patients. Genes (Basel). 2018, 9:524. 10.3390\/genes9110524","journal-title":"Genes (Basel)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22132","article-title":"Clinical and molecular characterization of limb-girdle muscular dystrophy due to LAMA2 mutations","volume":"44","author":"Gavassini BF","year":"2011","unstructured":"Gavassini BF, Carboni N, Nielsen JE, et al.. Clinical and molecular characterization of limb-girdle muscular dystrophy due to LAMA2 mutations. Muscle Nerve. 2011, 44:703-9. 10.1002\/mus.22132","journal-title":"Muscle Nerve"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-022-00347-0","article-title":"Splicing mutations in the CFTR gene as therapeutic targets","volume":"29","author":"Deletang K","year":"2022","unstructured":"Deletang K, Taulan-Cadars M. Splicing mutations in the CFTR gene as therapeutic targets. Gene Ther. 2022, 29:399-406. 10.1038\/s41434-022-00347-0","journal-title":"Gene Ther"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2006.06.013","article-title":"Genetic modifiers of muscular dystrophy: implications for therapy","volume":"1772","author":"Heydemann A","year":"2007","unstructured":"Heydemann A, Doherty KR, McNally EM. Genetic modifiers of muscular dystrophy: implications for therapy. Biochim Biophys Acta. 2007, 1772:216-28. 10.1016\/j.bbadis.2006.06.013","journal-title":"Biochim Biophys Acta"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/247708-exploring-splice-site-mutations-in-lama2-related-muscular-dystrophies-a-comprehensive-analysis-of-genotypic-and-phenotypic-patterns","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T16:39:01Z","timestamp":1717432741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/247708-exploring-splice-site-mutations-in-lama2-related-muscular-dystrophies-a-comprehensive-analysis-of-genotypic-and-phenotypic-patterns"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.61599","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,3]]}}}